Interviews

Although the decision in King v. Burwell will not directly affect states that have set up their own health insurance exchanges, they could see some benefits, according to David Blumenthal, MD, chief executive officer of The Commonwealth Fund.

On March 4 the Supreme Court will hear arguments in the case of King v. Burwell, which determines the fate of subsidies in the 34 federally facilitated marketplaces, and David Blumenthal, MD, chief executive officer of The Commonwealth Fund, outlined the potentially catastrophic effects if the Court were to side with the plaintiffs.

The goals of the new CMS Oncology Care Model align very nicely with what payers want, according to Ira M. Klein, MD, MBA, FACP, national medical director, clinical thought leadership, office of the chief medical officer, Aetna.

Some of the challenges with bringing as much focus to the mental well-being of patients as their physical conditions has to do with problems the healthcare industry created itself, according to Robin Henderson, PsyD.

The first job of the Camden Coalition of Healthcare Providers was to dig into the data of the city's hospitals and see who was using them. Half of the population, it turns out, according to Jeffrey Brenner, MD, chief executive officer of the Coalition.

As community oncology clinics affiliate with hospital systems to become hospital outpatient departments, patients begin to feel the burden of higher costs of care, according to Debra Patt, MD, from Texas Oncology, a community-based practice.

The concept of pathways is the most widely adopted solution to reduce the high cost of cancer care, according to Bruce Feinberg, DO, vice president and chief medical officer of oncology at Cardinal Health Specialty Solutions.

Over the last 20 years, The American Journal of Managed Care has published empirical, challenging work, according to Rajesh Balkrishnan, PhD, associate director for research and education at the University of Michigan Center for Global Health.

Among publications in the managed care field, The American Journal of Managed Care (AJMC) is likely the leader, according to Mitch DeKoven, principal of health economics and outcomes research at IMS Health.

Clinical trials are critical for pushing the oncology field forward, but there is a need for not only more patients to participate in clinical trials, but for a more diverse population, said Howard K. Kaufman, MD, FACS.

The term financial toxicity is relatively new and is being used to draw parallels between the physical toxicities of chemotherapy and the cost-related burdens cancer patients face.

With a Republican House and Senate and a Democrat governor, Arkansas had a difficult time passing Medicaid expansion legislation, explained Joe Thompson, MD, former state surgeon general.

For people who have cancer, patient-centered care is particularly important because their life is changing, said Amy Berman, RN, BS, senior program officer at the John A. Hartford Foundation, who also has stage 4 breast cancer.

At Patient-Centered Diabetes Care, hear stakeholders across the whole ecosystem of healthcare delivery discuss solutions for diabetes with the patient always at the center of the discussion.

Many hospitals and healthcare systems don't fully understand their true cost of care, which will make the transition to an outcomes-based system difficult, said Robert Pendleton, MD, chief medical quality officer for University of Utah Healthcare.

Although there is a clear link between nonadherence and outcomes of a patient with chronic myelogenous leukemia (CML), some patient intentionally stop taking their medication, said Giora Sharf, co-founder of the CML Advocates Network.

About 70% of primary care visits actually have a behavioral health component, which has been well known for some time, although people are only now getting serious about investing in mental healthcare, according to John Santopietro, MD, chief clinical officer of behavioral health at Carolinas HealthCare System.

Specialty drug costs represent a huge concern for Medicaid, which already represents the second largest budget in a state, according to J. Mario Molina, MD, president and chief executive officer of Molina Healthcare.

Expanding Medicaid under the Affordable Care Act is a huge undertaking, and Michigan decided to expand the program under a Section 1115 waiver, which sets the state apart a bit, according to Stephen Fitton, Medicaid Director at the Michigan Department of Community Health.

Of the many benefits that come from achieving a 4-star CMS rating or better, retention and growth are probably the biggest ones, according to Snezana Mahon, PharmD, senior director Medicare solutions at Express Scripts.

CMS audits have found that some health insurance plans are struggling with the same issues year after year, which is concerning, said Sarah J. Lorance, vice president of Medicare compliance at Anthem.

As the healthcare industry moves to a more consumerism based environment, the number one goal for health plans is to have affordable options, explained Karen Ignagni, president and chief executive officer of America's Health Insurance Plans.

Despite being used to dealing with drugs that are incredibly expensive, the high cost of Sovaldi presents a new problem for state Medicaid programs, according to Matt Salo, the executive director of the National Association of Medicaid Directors.

In order to reign in high costs of care in oncology, the healthcare community needs to be able to define value better, according to Alex Bastian, MBA, senior vice president at GfK.

Recent important changes in oncology have led to major advances that allow providers to recommend very specific therapies, said Mark G. Kris, MD, William and Joy Ruane chair in thoracic oncology at Memorial Sloan Kettering Cancer Center.

As the rate of chronic diseases has increased, so has interest in treating mental health issues, Brenda Reiss-Brennan, PhD, mental health integration director at Intermountain Healthcare, said at the US News Hospital of Tomorrow conference.

There are many dimensions to providing quality cancer care, but they're always tied to aligning the best outcomes with the patient's preferences, Peter P. Yu, MD, FASCO, 2014-2015 president of ASCO, said at the Patient-Centered Oncology Care meeting.

There are a couple of areas where interoperability can still be improved, which requires work from both the private and the public sector, said Steven Posnack, MS, MHS, director of the Office of Standards and Technology at the Office of the National Coordinator for Health Information Technology.

No entity in healthcare should have a blank check, but that's the current situation with specialty drugs, said Karen Ignagni, president and chief executive officer of America's Health Insurance Plans.

The evolving field of precision medicine is very much reliant on diagnostics, Howard K. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, said at The American Journal of Managed Care's Patient-Centered Oncology Care meeting.